HomeC26 • FRA
add
CellaVision AB
Previous close
€18.68
Day range
€18.14 - €18.14
Year range
€13.10 - €25.95
Market cap
4.95B SEK
Avg Volume
52.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 194.80M | 14.54% |
Operating expense | 80.09M | 9.35% |
Net income | 41.52M | 37.84% |
Net profit margin | 21.31 | — |
Earnings per share | 1.74 | 38.10% |
EBITDA | 62.52M | 26.92% |
Effective tax rate | 20.92% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 182.32M | 9.18% |
Total assets | 1.04B | 7.16% |
Total liabilities | 205.34M | -4.65% |
Total equity | 838.53M | — |
Shares outstanding | 23.85M | — |
Price to book | 0.53 | — |
Return on assets | 13.88% | — |
Return on capital | 16.76% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 41.52M | 37.84% |
Cash from operations | 61.43M | -13.92% |
Cash from investing | -21.19M | -25.95% |
Cash from financing | -3.48M | 65.59% |
Net change in cash | 32.89M | -27.46% |
Free cash flow | 18.47M | -56.85% |
About
Founded
1994
Website
Employees
228
